ACC Conference Review 2018

In this review:

Blood pressure reduction in black barbershops
SGLT-2 inhibitor therapy reduces CV risk in diabetics
Major adverse limb events in lower extremity PAD
Hospital performance affects survival after HF hospitalisation
Routine vs selective CMR in non-ischaemic HF
CV outcomes with alirocumab after ACS
Efficacy of a wearable cardioverterdefibrillator after MI
Loading atorvastatin doses in ACS with planned revascularisation
Carvedilol for preventing chemotherapy-induced cardiotoxicity
Six- vs 12-month DAPT after PCI for ACS

Please login below to download this issue (PDF)

Subscribe